医学
肿瘤科
荟萃分析
危险系数
内科学
佐剂
不利影响
化疗
新辅助治疗
辅助治疗
置信区间
随机对照试验
比例危险模型
癌症
乳腺癌
作者
Juan Fernando Paz Rojas,Carlos A Ballestas Almario,Herney Andrés García‐Perdomo
标识
DOI:10.1016/j.urolonc.2022.02.014
摘要
There were no differences when comparing adjuvant vs. neoadjuvant chemotherapy or adjuvant vs. no intervention chemotherapy. We conclude that progression-free survival had a better response with adjuvant chemotherapy when compared with neoadjuvant therapy. We suggest more studies with adequate design to offer a stronger recommendation.
科研通智能强力驱动
Strongly Powered by AbleSci AI